ANDA 74756, held by Cosette Pharms Nc. Selegiline Hydrochloride.
As of Nov 15, 2026, ANDA 74756 (Selegiline Hydrochloride), held by Cosette Pharms Nc, was first approved by FDA on Nov 25, 1998, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 25, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Selegiline Hydrochloride5MG ยท tablet;oral | Selegiline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
